Insuline Medical Valuation
| INSL Stock | ILS 210.00 8.00 3.96% |
At this time, the firm appears to be overvalued. Insuline Medical retains a regular Real Value of S190.05 per share. The prevalent price of the firm is S210.0. Our model calculates the value of Insuline Medical from evaluating the firm fundamentals such as Revenue of 40 K, price to earning of (40.77) X, and Cash And Equivalents of 1.15 M as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Insuline Medical's price fluctuation is very steady at this time. Calculation of the real value of Insuline Medical is based on 3 months time horizon. Increasing Insuline Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Insuline Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Insuline Stock. However, Insuline Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 210.0 | Real 190.05 | Hype 210.0 | Naive 184.91 |
The real value of Insuline Stock, also known as its intrinsic value, is the underlying worth of Insuline Medical Company, which is reflected in its stock price. It is based on Insuline Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Insuline Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Insuline Medical helps investors to forecast how Insuline stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Insuline Medical more accurately as focusing exclusively on Insuline Medical's fundamentals will not take into account other important factors: Insuline Medical Total Value Analysis
Insuline Medical is currently forecasted to have takeover price of 0 with market capitalization of 36.33 M, debt of 0, and cash on hands of 1.15 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Insuline Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 36.33 M | 0 | 1.15 M |
Insuline Medical Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Insuline suggests not a very effective usage of assets in November.Insuline Medical Profitability Analysis
The company reported the revenue of 40 K. Net Loss for the year was (7.01 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Insuline Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Insuline Medical and how it compares across the competition.
About Insuline Medical Valuation
The stock valuation mechanism determines Insuline Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Insuline Medical. We calculate exposure to Insuline Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Insuline Medical's related companies.8 Steps to conduct Insuline Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Insuline Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Insuline Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Insuline Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Insuline Medical's revenue streams: Identify Insuline Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Insuline Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Insuline Medical's growth potential: Evaluate Insuline Medical's management, business model, and growth potential.
- Determine Insuline Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Insuline Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Insuline Stock analysis
When running Insuline Medical's price analysis, check to measure Insuline Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insuline Medical is operating at the current time. Most of Insuline Medical's value examination focuses on studying past and present price action to predict the probability of Insuline Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insuline Medical's price. Additionally, you may evaluate how the addition of Insuline Medical to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |